Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)

NSE:ARISTO Revenue

In the fiscal year ending March 31, 2026, Aristo Bio-Tech and Lifescience had annual revenue of 3.64B INR with 14.34% growth. Aristo Bio-Tech and Lifescience had revenue of 1.07B in the half year ending March 31, 2026, a decrease of -4.50%.

• Revenue: 3.64B
• Revenue Growth: +14.34%
• P/S Ratio: 0.18
• Revenue / Employee: 55.11M
• Employees: 66
• Market Cap: 640.27M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.64B	456.25M	14.34%
Mar 31, 2025	3.18B	729.45M	29.76%
Mar 31, 2024	2.45B	272.92M	12.53%
Mar 31, 2023	2.18B	520.92M	31.43%
Mar 31, 2022	1.66B	-14.55M	-0.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 15, 2026

Data Sources Report a data error